CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 815 of 870
Non-Antibody Products
Page 815 of 870
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Torcetrapib | A CETP inhibitor (IC50s = 47 and 51 nM for cholesteryl and triglyceride tr… | 5 mg | 15028-5 | More Info |
| Torcetrapib | A CETP inhibitor (IC50s = 47 and 51 nM for cholesteryl and triglyceride tr… | 50 mg | 15028-50 | More Info |
| Toremifene (citrate) | A SERM that evokes tissue-dependent effects similar to that of tamoxifen | 100 mg | 20854-100 | More Info |
| Toremifene (citrate) | A SERM that evokes tissue-dependent effects similar to that of tamoxifen | 250 mg | 20854-250 | More Info |
| Toremifene (citrate) | A SERM that evokes tissue-dependent effects similar to that of tamoxifen | 50 mg | 20854-50 | More Info |
| Toremifene (citrate) | A SERM that evokes tissue-dependent effects similar to that of tamoxifen | 500 mg | 20854-500 | More Info |
| Toremifene-d6 | An internal standard for the quantification of toremifene by GC- or LC-MS | 1 mg | 30728-1 | More Info |
| Torin 1 | A potent and selective inhibitor of mTOR (IC50 = 2 and 10 nM for mTORC1 an… | 10 mg | 10997-10 | More Info |
| Torin 1 | A potent and selective inhibitor of mTOR (IC50 = 2 and 10 nM for mTORC1 an… | 25 mg | 10997-25 | More Info |
| Torin 1 | A potent and selective inhibitor of mTOR (IC50 = 2 and 10 nM for mTORC1 an… | 50 mg | 10997-50 | More Info |
| Torin 2 | An potent, selective inhibitor of cellular mTOR activity (EC50 = 0.3 nM) w… | 10 mg | 14185-10 | More Info |
| Torin 2 | An potent, selective inhibitor of cellular mTOR activity (EC50 = 0.3 nM) w… | 25 mg | 14185-25 | More Info |
| Torin 2 | An potent, selective inhibitor of cellular mTOR activity (EC50 = 0.3 nM) w… | 5 mg | 14185-5 | More Info |
| Tormentic Acid | A triterpene with diverse biological activities; reduces hydrogen peroxide… | 1 mg | 30696-1 | More Info |
| Tormentic Acid | A triterpene with diverse biological activities; reduces hydrogen peroxide… | 10 mg | 30696-10 | More Info |
| Tormentic Acid | A triterpene with diverse biological activities; reduces hydrogen peroxide… | 5 mg | 30696-5 | More Info |
| Tosedostat | An aminopeptidase inhibitor (IC50s = 100, 150, and 220 nM for LAP, PUSA, a… | 1 mg | 23395-1 | More Info |
| Tosedostat | An aminopeptidase inhibitor (IC50s = 100, 150, and 220 nM for LAP, PUSA, a… | 5 mg | 23395-5 | More Info |
| Tosufloxacin (tosylate) | A fluoroquinolone antibiotic | 1 g | 21427-1 | More Info |
| Tosufloxacin (tosylate) | A fluoroquinolone antibiotic | 100 mg | 21427-100 | More Info |
| Tosufloxacin (tosylate) | A fluoroquinolone antibiotic | 250 mg | 21427-250 | More Info |
| Tosufloxacin (tosylate) | A fluoroquinolone antibiotic | 500 mg | 21427-500 | More Info |
| Tosyllysine Chloromethyl Ketone (hydrochloride) | An active site-directed agent that inhibits serine proteinases with trypsi… | 100 mg | 13074-100 | More Info |
| Tosyllysine Chloromethyl Ketone (hydrochloride) | An active site-directed agent that inhibits serine proteinases with trypsi… | 250 mg | 13074-250 | More Info |
| Tosyllysine Chloromethyl Ketone (hydrochloride) | An active site-directed agent that inhibits serine proteinases with trypsi… | 50 mg | 13074-50 | More Info |
| Tosyl Phenylalanyl Chloromethyl Ketone | An irreversible inhibitor of chymotrypsin-like proteases that has been sho… | 1 g | 20166-1 | More Info |
| Tosyl Phenylalanyl Chloromethyl Ketone | An irreversible inhibitor of chymotrypsin-like proteases that has been sho… | 100 mg | 20166-100 | More Info |
| Tosyl Phenylalanyl Chloromethyl Ketone | An irreversible inhibitor of chymotrypsin-like proteases that has been sho… | 250 mg | 20166-250 | More Info |
| Tosyl Phenylalanyl Chloromethyl Ketone | An irreversible inhibitor of chymotrypsin-like proteases that has been sho… | 500 mg | 20166-500 | More Info |
| Total and Direct Bilirubin Colorimetric Assay Kit | Cayman's Total and Direct Bilirubin Colorimetric Assay provides a rapid, r… | 1 ea | 701720-1EA | More Info |
| Total Collagen/Hydroxyproline Assay Kit | Cayman's Total Collagen / Hydroxyproline Assay Kit provides colorimetric-b… | 96 Well | 702440-96WELLS | More Info |
| Total Iron-Binding Capacity (TIBC) and Serum Iron Assay Kit | Cayman's Total Iron-Binding Capacity (TIBC) and Serum Iron Assay Kit provi… | 1 ea | 702230-1EA | More Info |
| Totarol | A diterpene with diverse biological activities; active against Gram-positi… | 100 mg | 26412-100 | More Info |
| Totarol | A diterpene with diverse biological activities; active against Gram-positi… | 250 mg | 26412-250 | More Info |
| Totarol | A diterpene with diverse biological activities; active against Gram-positi… | 50 mg | 26412-50 | More Info |
| Totarol | A diterpene with diverse biological activities; active against Gram-positi… | 500 mg | 26412-500 | More Info |
| Toxin A from Clostridium difficile | An enterotoxin that inactivates host Rho family GTPases by glucosylation,… | 100 µg | 19664-100 | More Info |
| Toxin B from Clostridium difficile | A cytotoxin that inactivates host Rho family GTPases by glucosylation, alt… | 50 µg | 19665-50 | More Info |
| Toyocamycin (hydrate) | A natural adenosine analog that prevents IRE1α-induced mRNA cleavage… | 1 mg | 17371-1 | More Info |
| Toyocamycin (hydrate) | A natural adenosine analog that prevents IRE1α-induced mRNA cleavage… | 10 mg | 17371-10 | More Info |
| Toyocamycin (hydrate) | A natural adenosine analog that prevents IRE1α-induced mRNA cleavage… | 25 mg | 17371-25 | More Info |
| Toyocamycin (hydrate) | A natural adenosine analog that prevents IRE1α-induced mRNA cleavage… | 5 mg | 17371-5 | More Info |
| Tozadenant | An adenosine A2A receptor antagonist (Kis = 11.5 and 6 nM for human and rh… | 10 mg | 28452-10 | More Info |
| Tozadenant | An adenosine A2A receptor antagonist (Kis = 11.5 and 6 nM for human and rh… | 100 mg | 28452-100 | More Info |
| Tozadenant | An adenosine A2A receptor antagonist (Kis = 11.5 and 6 nM for human and rh… | 25 mg | 28452-25 | More Info |
| Tozadenant | An adenosine A2A receptor antagonist (Kis = 11.5 and 6 nM for human and rh… | 50 mg | 28452-50 | More Info |
| TP-0463518 | A pan HIF-PH inhibitor; inhibits human HIF-PH1 (Ki = 5.3 nM), as well as h… | 10 mg | 33788-10 | More Info |
| TP-0463518 | A pan HIF-PH inhibitor; inhibits human HIF-PH1 (Ki = 5.3 nM), as well as h… | 25 mg | 33788-25 | More Info |
| TP-0463518 | A pan HIF-PH inhibitor; inhibits human HIF-PH1 (Ki = 5.3 nM), as well as h… | 5 mg | 33788-5 | More Info |
| TP-0463518 | A pan HIF-PH inhibitor; inhibits human HIF-PH1 (Ki = 5.3 nM), as well as h… | 50 mg | 33788-50 | More Info |
| TP-064 | A potent inhibitor of PRMT4 (IC50 50 = 43 nM) in vitro, | 1 mg | 20256-1 | More Info |
| TP-064 | A potent inhibitor of PRMT4 (IC50 50 = 43 nM) in vitro, | 10 mg | 20256-10 | More Info |
| TP-064 | A potent inhibitor of PRMT4 (IC50 50 = 43 nM) in vitro, | 25 mg | 20256-25 | More Info |
| TP-064 | A potent inhibitor of PRMT4 (IC50 50 = 43 nM) in vitro, | 5 mg | 20256-5 | More Info |
| TP-0903 | An inhibitor of Axl (IC50 = 27 nM ); exhibits greater than 50% inhibition… | 1 mg | 28757-1 | More Info |
| TP-0903 | An inhibitor of Axl (IC50 = 27 nM ); exhibits greater than 50% inhibition… | 10 mg | 28757-10 | More Info |
| TP-0903 | An inhibitor of Axl (IC50 = 27 nM ); exhibits greater than 50% inhibition… | 25 mg | 28757-25 | More Info |
| TP-0903 | An inhibitor of Axl (IC50 = 27 nM ); exhibits greater than 50% inhibition… | 5 mg | 28757-5 | More Info |
| TP-3654 | A Pim kinase inhibitor (Kis = 5, 239, and 42 nM for Pim-1, Pim-2, and Pim-… | 10 mg | 29571-10 | More Info |
| TP-3654 | A Pim kinase inhibitor (Kis = 5, 239, and 42 nM for Pim-1, Pim-2, and Pim-… | 25 mg | 29571-25 | More Info |
| TP-3654 | A Pim kinase inhibitor (Kis = 5, 239, and 42 nM for Pim-1, Pim-2, and Pim-… | 5 mg | 29571-5 | More Info |
| TP-472 | A BRD9 inhibitor (Kd = 33 nM; EC50 = 320 nM in a NanoBRET assay); >30-fold… | 1 mg | 20030-1 | More Info |
| TP-472 | A BRD9 inhibitor (Kd = 33 nM; EC50 = 320 nM in a NanoBRET assay); >30-fold… | 5 mg | 20030-5 | More Info |
| TP-4748 | A heterocyclic building block; has been used in the synthesis of prolyl-tR… | 10 mg | 31459-10 | More Info |
| TP-4748 | A heterocyclic building block; has been used in the synthesis of prolyl-tR… | 25 mg | 31459-25 | More Info |
| TP-4748 | A heterocyclic building block; has been used in the synthesis of prolyl-tR… | 50 mg | 31459-50 | More Info |
| TP-808 | An intermediate in the synthesis of synthetic tetracycline antibiotics, | 100 mg | 24181-100 | More Info |
| TP-808 | An intermediate in the synthesis of synthetic tetracycline antibiotics, | 250 mg | 24181-250 | More Info |
| TP-808 | An intermediate in the synthesis of synthetic tetracycline antibiotics, | 50 mg | 24181-50 | More Info |
| TP-060 | An inhibitor of UDP-glucose ceramide glucosyltransferase (IC50 = 0.031 &mi… | 1 mg | 41127-1 | More Info |
| TP-060 | An inhibitor of UDP-glucose ceramide glucosyltransferase (IC50 = 0.031 &mi… | 5 mg | 41127-5 | More Info |
| TP53BP1 BRCT domains (human, recombinant) | Source: Recombinant human N-terminal GST-tagged protein expressed in E. co… | 100 µg | 14171-100 | More Info |
| TP53BP1 BRCT domains (human, recombinant) | Source: Recombinant human N-terminal GST-tagged protein expressed in E. co… | 25 µg | 14171-25 | More Info |
| TP53BP1 BRCT domains (human, recombinant) | Source: Recombinant human N-terminal GST-tagged protein expressed in E. co… | 50 µg | 14171-50 | More Info |
| TP53BP1 tudor-like region (human recombinant) | Source: Recombinant N-terminal GST-tagged protein expressed in E. coli &bu… | 100 µg | 14073-100 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile